Effects of physiological hyperglycemia on duodenal motility and flow events, glucose absorption, and incretin secretion in healthy humans

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 8, 2010, Pages 3893-3900

  Kuo, Paul ^a   Wishart, Judith M ^a   Bellon, Max ^b   Smout, André J ^c   Holloway, Richard H ^b   Fraser, Robert J L ^a   Horowitz, Michael ^a   Jones, Karen L ^a   Rayner, Christopher K ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLGLUCOSE; CARBON 14; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN;

ADULT; ARTICLE; BLOOD LEVEL; CATHETER; DUODENUM MOTILITY; FEMALE; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; HORMONE RELEASE; HUMAN; HYPERGLYCEMIA; IMPEDANCE; INTESTINE PRESSURE; MALE; MANOMETRY; NORMAL HUMAN; PRIORITY JOURNAL; VOLUNTEER;

EID: 77955358073     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2514     Document Type: Article

References (37)

1. Rayner CK, Schwartz MP, van Dam PS, Renooij W, de Smet M, Horowitz M, Smout AJ, Samsom M 2002 Small intestinal glucose absorption and duodenal motility in type 1 diabetes mellitus. Am J Gastroenterol 97:3123-3130 (Pubitemid 35424585)
2. Chaikomin R, Wu KL, Doran S, Jones KL, Smout AJ, Renooij W, Holloway RH, Meyer JH, Horowitz M, Rayner CK 2007 Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release. Am J Physiol Gastrointest Liver Physiol 292: G1099-G1104 (Pubitemid 46557785)
3. Kellett GL, Brot-Laroche E 2005 Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes 54:3056-3062 (Pubitemid 41401109)
4. Kuo P, Bellon M, Smout A, Holloway RH, Fraser RJ, Horowitz M, Jones KL, Rayner C 2009 Effects of metoclopramide on duodenal motility and flow events, and glucose absorption, in healthy humans. Gastroenterology 136:1A (Abstract T1285)
5. Heddle R, Dent J, Toouli J, Read NW 1988 Topography and measurement of pyloric pressure waves and tone in humans. Am J Physiol 255:G490-G497
6. Rayner CK, Verhagen MA, Hebbard GS, DiMatteo AC, Doran SM, Horowitz M 2000 Proximal gastric compliance and perception of distension in type 1 diabetes mellitus: effects of hyperglycemia. Am J Gastroenterol 95:1175-1183 (Pubitemid 30263509)
7. Kuo P, Chaikomin R, Bellon M, Horowitz M, Jones KL, Rayner C 2009 Validation of 14C-3-O-methylglucose as a marker of glucose absorption. Gastroenterology 136:4 (Abstract T1284)
8. Samsom M, Akkermans LM, Jebbink RJ, van Isselt H, vanBerge- Henegouwen GP, Smout AJ 1997 Gastrointestinal motor mechanisms in hyperglycaemia induced delayed gastric emptying in type I diabetes mellitus. Gut 40:641-646
9. Hasler WL, Soudah HC, Dulai G, Owyang C 1995 Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. Gastroenterology 108:727-736
10. Kuo P, Gentilcore D, Nair N, Stevens JE, Wishart JM, Lange K, Gilja OH, Hausken T, Horowitz M, Jones KL, Rayner CK 2009 The nitric oxide synthase inhibitor, N(g)-nitro-l-arginine-methyl-ester, attenuates the delay in gastric emptying induced by hyperglycaemia in healthy humans. Neurogastroenterol Motil 21:1175-e103
11. Verhagen MA, Rayner CK, Andrews JM, Hebbard GS, Doran SM, Samsom M, Horowitz M 1999 Physiological changes in blood glucose do not affect gastric compliance and perception in normal subjects. Am J Physiol 276:G761-G766 (Pubitemid 29157443)
12. Hebbard GS, Samsom M, Sun WM, Dent J, Horowitz M 1996 Hyperglycemia affects proximal gastric motor and sensory function during small intestinal triglyceride infusion. Am J Physiol 271: G814-G819 (Pubitemid 26404730)
13. Björnsson ES, Urbanavicius V, Eliasson B, Attvall S, Smith U, Abrahamsson H 1994 Effects of hyperglycemia on interdigestive gastrointestinal motility in humans. Scand J Gastroenterol 29:1096-1104 (Pubitemid 24374800)
14. Byrne MM, Pluntke K, Wank U, Schirra J, Arnold R, Göke B, Katschinski M 1998 Inhibitory effects of hyperglycaemia on fed jejunal motility: potential role of hyperinsulinaemia. Eur J Clin Invest 28:72-78 (Pubitemid 28062482)
15. Russo A, Fraser R, Horowitz M 1996 The effect of acute hyperglycaemia on small intestinal motility in normal subjects. Diabetologia 39:984-989 (Pubitemid 26249119)
16. Nolte LA, Rincón J, Wahlström EO, Craig BW, Zierath JR, Wallberg- Henriksson H 1995 Hyperglycemia activates glucose transport in rat skeletal muscle via a Ca(2+)-dependent mechanism. Diabetes 44:1345-1348
17. Maenz DD, Cheeseman CI 1986 Effect of hyperglycemia on Dglucose transport across the brush-border and basolateral membrane of rat small intestine. Biochim Biophys Acta 860:277-285
18. Fischer E, Lauterbach F 1984 Effect of hyperglycaemia on sugar transport in the isolated mucosa of guinea-pig small intestine. J Physiol 355:567-586 (Pubitemid 14044721)
19. Csáky TZ, Fischer E 1977 Induction of an intestinal epithelial sugar transport system by high blood sugar. Experientia 33:223-224 (Pubitemid 8040003)
20. Bihler I, Freund N 1975 Sugar transport in the small intestine of obese hyperglycemic, fed and fasted mice. Diabetologia 11:387-393
21. Burant CF, Flink S, DePaoli AM, Chen J, Lee WS, Hediger MA, Buse JB, Chang EB 1994 Small intestine hexose transport in experimental diabetes. Increased transporter mRNA and protein expression in enterocytes. J Clin Invest 93:578-585
22. Corpe CP, Basaleh MM, Affleck J, Gould G, Jess TJ, Kellett GL 1996 The regulation of GLUT5 and GLUT2 activity in the adaptation of intestinal brush-border fructose transport in diabetes. Pflugers Arch 432:192-201
23. Adachi T, Mori C, Sakurai K, Shihara N, Tsuda K, Yasuda K 2003 Morphological changes and increased sucrase and isomaltase activity in small intestines of insulin-deficient and type 2 diabetic rats. Endocr J 50:271-279
24. Tormo MA, Martínez IM, Romerode Tejada A, Gil-Exojo I, Campillo JE 2002 Morphological and enzymatic changes of the small intestine in an n0-STZ diabetes rat model. Exp Clin Endocrinol Diabetes 110:119-123
25. Fujita Y, Kojima H, Hidaka H, Fujimiya M, Kashiwagi A, Kikkawa R 1998 Increased intestinal glucose absorption and postprandial hyperglycaemia at the early step of glucose intolerance in Otsuka Long-Evans Tokushima Fatty rats. Diabetologia 41:1459-1466
26. Ferraris RP, Casirola DM, Vinnakota RR 1993 Dietary carbohydrate enhances intestinal sugar transport in diabetic mice. Diabetes 42:1579-1587
27. Dyer J, Wood IS, Palejwala A, Ellis A, Shirazi-Beechey SP 2002 Expression of monosaccharide transporters in intestine of diabetic humans. Am J Physiol Gastrointest Liver Physiol 282:G241-G248
28. Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, Rizza RA 2001 Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes 50:1351-1362
29. Tobin V, Le Gall M, Fioramonti X, Stolarczyk E, Blazquez AG, Klein C, Prigent M, Serradas P, Cuif MH, Magnan C, Leturque A, Brot-Laroche E 2008 Insulin internalizes GLUT2 in the enterocytes of healthy but not insulin-resistant mice. Diabetes 57:555-562
30. Mace OJ, Affleck J, Patel N, Kellett GL 2007 Sweet taste receptors in rat small intestine stimulate glucose absorption through apical GLUT2. J Physiol 582:379-392
31. Young RL, Sutherland K, Pezos N, Brierley SM, Horowitz M, Rayner CK, Blackshaw LA 2009 Expression of taste molecules in the upper gastrointestinal tract in humans with and without type 2 diabetes. Gut 58:337-346
32. Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ 2003 Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 88:2706-2713
33. Vilsbøll T, Krarup T, Deacon CF, Madsbad S, Holst JJ 2001 Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 50:609-613
34. Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE, Meier JJ 2008 Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 57: 678-687
35. Vollmer K, Gardiwal H, Menge BA, Goetze O, Deacon CF, Schmidt WE, Holst JJ, Meier JJ 2009 Hyperglycemia acutely lowers the postprandial excursions of glucagon-like peptide-1 and gastric inhibitory polypeptide in humans. J Clin Endocrinol Metab 94:1379-1385
36. Little TJ, Doran S, Meyer JH, Smout AJ, O'Donovan DG, Wu KL, Jones KL, Wishart J, Rayner CK, Horowitz M, Feinle-Bisset C 2006 The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed. Am J Physiol Endocrinol Metab 291:E647-E655
37. Parker HE, Reimann F, Gribble FM 2010 Molecular mechanisms underlying nutrient-stimulated incretin secretion. Expert Rev Mol Med 12:e1